Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| SUMMER INFAN | SUMR | 7.23% |
| NATUS MEDICA | BABY | 5.86% |
| RADIANT LOGI | RLGT | 5.85% |
| NEW ORIENTAL | EDU | 4.66% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Nissan Motor Co. ( NSANY ) posted a 7% increase in profits to ¥341.43 billion ($4.32 billion) or ¥81.67 ($1.03) per share in fiscal 2011 ended March 31, 2012 compared with ¥319.22 billion or ¥76.44 in the prior fiscal year. However, the EPS was lower than the Zacks Consensus Estimate of $1.88.
Sales in the quarter appreciated 7% to ¥9.41 trillion ($118.95 billion) in the year. Operating profit inched up 2% to ¥545.84 billion ($6.90 billion) from ¥537.47 billion in fiscal 2010.
The improvement in revenues and profits was attributable to strong demand for the company’s vehicles, frequent product launches during the year and market expansion programs. The company believes investments in manufacturing capacity expansion, particularly in China, North America, Brazil and Russia, will enhance sales volume of the company.
The company released five new models during the year including Tiida in China, Lafesta Highway Star in Japan, front-drive and rear-drive versions of the NV400 commercial van in Europe and the Infiniti JX in the U.S.
Due to these factors, the automaker recovered earlier from the disruptions caused by the twin disasters in Japan and severe flooding in Thailand last year compared with its domestic rivals, Toyota Motor Corp. ( TM - Analyst Report ) and Honda Motor Co. ( HMC - Analyst Report ) .
In the fiscal year, Nissan’s global sales totaled 4.85 million units, up 16% from 4.18 million units last year. With this, the company has outperformed the growth in total industry volumes of 4.2% to 75.7 million units from 72.6 million units in fiscal 2010. Globally, it acquired a market share of 6.4% during the year, up 0.6 percentage points from the prior year.
Nissan’s sales in its largest market, China, improved 22% to 1.25 million units. Meanwhile, its sales rose 12% to 1.08 million units in the U.S., 17.5% to 713,000 units across Europe (including Russia), 9% to 655,000 units in Japan and 16% to 826,000 units in Other markets.
For fiscal 2012 ending March 31, 2013, Nissan expects revenues of ¥10.3 trillion ($125.61 billion) based on a 10.4% increase in unit sales to 5.35 million. The company plans to launch 10 products globally including Altima, Pathfinder, Sylphy/Sentra, NV350 Caravan and a long wheelbase version of the Infiniti M hybrid sedan. It has aimed for product launches averaging every six weeks and expand its Infiniti and light commercial vehicle businesses.
The company also anticipates operating profit of ¥700 billion ($8.54 billion) and net income of ¥400 billion ($4.88 billion) for the year. The company has succeeded in cutting purchasing costs by 5% annually and aims to reduce total costs by 5% each year.
Nissan Motor, founded in 1933 and headquartered in Yokohama-shi, Japan, together with its subsidiaries, engages in the manufacture and sale of automotive products, industrial machinery and marine equipment primarily in Japan, North America, and Europe. The company offers passenger cars, trucks, buses, forklifts, light commercial vehicles, power trains and parts, as well as sales financing activities.
Due to better than expected recovery, promising results and clear-cut outlook, the company currently retains a Zacks #2 Rank on its stock, which translates to a short-term (1 to 3 months) rating of Buy.
Read the full on NSANY
Read the full Analyst Report on HMC
Read the full Analyst Report on TM